| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Allogene Therapeutics, Inc. | Director | Common Stock | 308K | $664K | $2.16 | Dec 5, 2024 | Direct |
| Allogene Therapeutics, Inc. | Director | Stock Option (Right to buy) | 95.5K | Jun 5, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics, Inc. | Dec 5, 2024 | 1 | -$19.9K | 4 | Dec 9, 2024 | Director |
| ALLO | Allogene Therapeutics, Inc. | Jun 5, 2024 | 2 | $0 | 4 | Jun 7, 2024 | Director |
| ALLO | Allogene Therapeutics, Inc. | May 30, 2024 | 1 | -$26.2K | 4 | Jun 3, 2024 | Director |
| ALLO | Allogene Therapeutics, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
| ALLO | Allogene Therapeutics, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
| ALLO | Allogene Therapeutics, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 11, 2021 | Director |